earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Lexicon Pharmaceuticals Inc (LXRX) SEC filings
Lexicon Pharmaceuticals Inc (LXRX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported LXRX revenue for 2025-12-31 was $49.8M. Net income was -$50.3M. Revenue was up 60.2% from 2024-12-31 to 2025-12-31. LXRX currently screens at market cap $327.2M. The LXRX filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Lexicon Pharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsearnings call
Event insights for LXRX — what management said, what changed, and why it matters.
Recent filings
8-K2.029.01
EDGARLXRX SEC filings FAQ
What is the latest LXRX SEC filing?
The latest cached Lexicon Pharmaceuticals Inc (LXRX) filing on this page is 8-K · Aug 6, 2026. Filings: https://lician.com/sec/lxrx
What is the latest LXRX filing accession number?
The latest cached Lexicon Pharmaceuticals Inc (LXRX) accession number on this page is 0001062822-26-000112. Filing: https://lician.com/sec/lxrx/0001062822-26-000112
Which item codes are on the latest LXRX filing?
Cached item codes on the latest Lexicon Pharmaceuticals Inc (LXRX) 8-K are 2.02, 9.01.
How many LXRX SEC filings are listed on this page?
This page lists 1 cached Lexicon Pharmaceuticals Inc (LXRX) SEC filing. Filings: https://lician.com/sec/lxrx
What events are listed on the LXRX SEC page?
Cached event headlines on this Lexicon Pharmaceuticals Inc (LXRX) SEC page: "LXRX earnings". Events: https://lician.com/sec/lxrx
What are LXRX's latest revenue and net income?
Latest cached Lexicon Pharmaceuticals Inc (LXRX) revenue for Dec 31, 2025 was $49.8M. Net income was -$50.3M. Statements: https://lician.com/financials/lxrx